Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Ebos Group Ltd Announces Acquisition Of Zuellig Healthcare Holdings Australia Pty Ltd


Tuesday, 28 May 2013 04:31pm EDT 

Ebos Group Ltd (EBOS) announced that it will acquire Australia's leading pharmaceutical wholesaler and distributor by revenue and a leading veterinary wholesale provider with economic effect from June 1, 2013. The announcement comes after several months of intensive due diligence, culminating in EBOS entering into an agreement to acquire Zuellig Healthcare Holdings Australia Pty Ltd (Symbion), a 100% owned subsidiary of The Zuellig Group Incorporated (Zuellig). The cash portion of the acquisition purchase price ($367 million) is to be funded by an underwritten share placement to institutional investors, a 7 for 20 pro-rata renounceable entitlement offer and an extension of EBOS' debt facilities, while the remainder of the purchase price ($498 million) will be satisfied through an issue of new EBOS shares to Zuellig.The acquisition price of Symbion will be $865 million, excluding the transfer to EBOS of existing Symbion debt. 

Related Company News

Company Quote

9.59
0.14 +1.48%
27 Aug 2014